***** Coming up on May 11th: BDI's Social Communications & Healthcare event - half day session in NYC with Case Studies and Roundtables (I'll be leading one of the roundtables). Top speakers from …
Impactiviti Daily 033010
***** TODAY’S NEWS Patenting genes called into question. Frankly, this is a legal/medical/sociological discussion that needs to happen. Cephalon's jet lag indication on Nuvigil may be stuck on …
Impactiviti Daily 032910
***** TODAY’S NEWS Antisoma/Novartis experimental drug hits the proverbial wall on Phase III lung cancer trial. Study halted. New test may predict which MS patients will most benefit from beta …
Impactiviti Daily 032510
***** TODAY’S NEWS What about those bone fracture risks with biophosphonate drugs? The jury is still out - A new study gives reassuring news about the safety of Fosamax and Reclast, bone-building …
Impactiviti Daily 031610
***** TODAY’S NEWS AstraZeneca still waiting for the upside of MedImmune acquisition. Pfizer: More Lipitor, fewer heart complications - A reanalysis of research data found a high dose of popular …
Pharma Blogging/Tweeting: One or Many?
As more and more pharmaceutical companies dip their toes into social media, one of the issues that surfaces regularly is this: do you put someONE in charge of a blog and/or Twitter account, or do you …
Continue Reading about Pharma Blogging/Tweeting: One or Many? →